The trademark application EPISERAS was filed by NEURAXPHARM PHARMACEUTICALS, S.L., a corporation established under the laws of the Kingdom of Spain (the "Applicant"). The application was published for oppositions on May 14, 2023, and it was registered by office on August 21, 2023 without any oppositions.
It was designated 'Basic Application' for International Application 1755416 at the World Intellectual Property Organization (WIPO).
The application was filed in Spanish (English was selected as the second language).
Change of name and address of the trademark registration was recorded on May 22, 2023.
Goods And Services
The mark was filed in class 9 with following description of goods:
Mobile applications featuring artificial intelligence for determining epilepsy seizure risks in real time
Mobile applications for epilepsy prediction, data management and monitoring
Software and applications for mobile devices for the medical industry, in particular for epileptic seizures
Software as a medical device [SaMD], downloadable
Epilepsy prediction and monitoring software
Artificial intelligence software for epileptic seizure care
Product engineering software
Intelligent Character Recognition [ICR] software
Brain activity recognition software
Application development software
Sensory software
Scientific, research, measuring, detecting and testing apparatus and instruments
Apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data
Recorded or downloadable media, Digital recording and storage media.
The mark was filed in class 10 with following description of goods:
Medical device, for use in the following fields: For epileptic seizure prediction in real time
Devices for medical use, for use in the following fields: treatment of epilepsy
Devices for medical use, for use in the following fields: Epilepsy seizure monitoring, data management and prediction.
The mark was filed in class 44 with Medical services for treating epilepsy.